Celadon Pharmaceuticals

75 days ago

Celadon CEO James Short now on very thin ice indeed as more bills go unpaid, but has he taken out any cash?

Celadon Pharmaceuticals (CEL) told us on March 31 that it had sufficient cash to last “into April” thanks to the support of creditors. In plain English it could last as long as various folks did not insist on being paid. Today it says that, with the same caveat, it can now last “into May.” CEO James Short is a proven chancer.

101 days ago

Celadon – can’t it be more specific about when it will go bust?

For two RNS’s on the trot Celadon Pharmaceuticals (CEL) has, while lamenting the failure of two finance providers to provide contracted loan finance, warned that, even with creditors not demanding immediate repayment , it only has enough cash to last it “in to April.” It is now April 4.

103 days ago

Celadon: Timber! The Fat Lady is warming up!

“Oh dear, oh dear” as disgraced ex tipster Mike Walters would say when yet another of his share tips went horribly Pete Tong. No money, guzzling cash, likely to delist, a blue sky jam tomorrow story and run by rule breaking shysters, Celadon Pharmaceuticals (CEL) is just the sort of dog Walters would have tipped. Yesterday it waited until I was on the school run for its latest bad news. The shares, 125p two years ago when I first called this out, are now 3.5p.

148 days ago

Tom Winnifrith Bearcast No 1: Winding up orders and two companies that could be brown bread by May (or much sooner)

The two companies are old favourites of this website, Hellenic Dynamics (HELD) and Celadon Pharmaceuticals (CEL). The latter has just had a cash windfall but that will get creditors onto the front foot, the former faces a very unusual winding up claim today. It is interesting.

164 days ago

Celadon Pharmaceuticals: oh dear, oh dear, oh dear, a financing update

There were folks out there who, naively, thought that the announcement about a “strategic collaboration” from Celadon Pharmaceuticals (CEL) two weeks ago would stave off its cash crisis. I warned it would not but the shares raced ahead to 36p anyway. Okay he has called this bag of shite correctly all the way down from 125p but what does useless old failed fund manager TW know? Today the shares are 13.5p as the company has ‘fessed.

190 days ago

Celadon Pharmaceuticals: death postponed is still death

Celadon Pharmaceuticals (CEL) has yet to respond to the shocking suggestion that its CEO, via a third party, funded the last £150,000 paid for by an investor who would otherwise have welched on his deal. Meanwhile progress, of sort, from the bloke who welched on a £1 million loan.

225 days ago

EXPOSE: Has Graham Bond of RSM been a very naughty boy with his Celadon homework?

Over at Celadon Pharmaceuticals (CEL) auditor Graham Bond of RSM signed off on 13 May 2024 after the Post Balance Sheet Fundraise on 10 May 2024 noted in the accounts. Given the fund raise was specifically highlighted as a relevant factor in the going concern assessment, the auditor RSM should have audited the note carefully given he must have relied on Fundraise to issue a clean going concern opinion.

238 days ago

Celadon: Timber! More ouzo for the Sheriff, vicar?

If AIM was not such a joke then James Short, the CEO of Celadon Pharmaceuticals (CEL) would have been fired months ago for his tardy disclosure that sums owed from a May loan and equity investment agreement did not arrive on schedule. And they have still not arrived leaving the company in crisis, as it ‘fessed up to today.

552 days ago

Celadon statement needed ASAP as shares continue to tank: still a £60m short

I really do hope that in penning this piece I am not going to interrupt another feminazi lunch being attended by Celadon Pharmaceuticals (CEL) PR head honcho Ms. Sarah McLeod. For I fear that Ms McLeod needs to stop discussing the gender pay gap and ensure her client – a company I have oft warned is drowning in red flags – to issue a statement as its share price continues to tumble. Here’s why?

843 days ago

Tom Winnifrith Bearcast: The next Prime Minister gives a kiss of death to Ceres Power

Tomorrow is my third training walk for Rogue Bloggers for Woodlarks. I am targeting 11 miles and will post a picture of the service station on the Wrexham roundabout which is my turnaround point if we can get donations well above £1,000 before I leave. I can’t say fairer than that, please donate HERE. In today’s podcast I discuss Deutsche Bank ( the next Credit Suisse?), the fraud Supply@ME Capital (SYME), nanosynth (NNN), Kefi Gold & Copper (KEFI), Ceres Power (CWR), Genflow Biosciences (GENF) and Celadon Pharmaceuticals (CEL) and lock in expiries in a thin market.

843 days ago

Celadon Pharmaceuticals – a correction and a lockin issue, welcome back John Story

Just as I highlighted yesterday HERE, all the reasons why Celadon Pharmaceuticals (CEL) was ludicrously overpriced, a co conspirator was one of hundreds if not thousands of folks receiving a whatsapp message on the very same company, a mass spamming by the disgraced John Story. Remember him?

843 days ago

Tom Winnifrith Bearcast: And today's big new shorting idea is...Celadon Pharmaceuticals

I start with a grumpy old man rant about standards in public and corporate life covering a lying Boris, Wildcat (WCAT) and Osirium (OSI) before moving onto the missing £20 million and the fraud Supply@ME Capital (SYME). I cover Amigo (AMGO), Versarien (VRS) and the liquidity trap, Inland (INL), Advanced Oncotherapy (AVO) before I turn my fire on Celadon (CEL). Finally I urge you to donate to Rogue Bloggers for Woodlarks as I outline my third training walk on Saturday. C’mon you can afford a tenner HERE